Multiple interactions recruit MLL1 and MLL1 fusion proteins to the HOXA9 locus in leukemogenesis.

Multiple interactions recruit MLL1 and MLL1 fusion proteins to the HOXA9 locus in leukemogenesis.

Toon andere (1) versies

MLL1 fusion proteins activate HoxA9 gene expression and cause aggressive leukemias that respond poorly to treatment, but how they recognize and stably bind to HoxA9 is not clearly understood. In a systematic analysis of MLL1 domain recruitment activity, we identified an essential MLL1 recruitment do...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Milne, T, Kim, J, Wang, G, Stadler, S, Basrur, V, Whitcomb, S, Wang, Z, Ruthenburg, A, Elenitoba-Johnson, K, Roeder, R, Allis, C
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2010

Gelijkaardige items

Multiple Interactions Recruit MLL1 and MLL1 Fusion Proteins to the HOXA9 Locus in Leukemogenesis
door: Milne, T, et al.
Gepubliceerd in: (2010)

Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes.
door: Biswas, D, et al.
Gepubliceerd in: (2011)

Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis.
door: Ballabio, E, et al.
Gepubliceerd in: (2012)

Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.
door: Zeisig, B, et al.
Gepubliceerd in: (2004)

Regulation of MLL1 H3K4 methyltransferase activity by its core components.
door: Dou, Y, et al.
Gepubliceerd in: (2006)

PAF1 and FACT cooperate with MLL-AF4 to drive enhancer activity in leukemia
door: Milne, T, et al.
Gepubliceerd in: (2022)

Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis.
door: Daser, A, et al.
Gepubliceerd in: (2004)

MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia
door: Crump, NT, et al.
Gepubliceerd in: (2023)

Cdx4 is dispensable for murine adult hematopoietic stem cells but promotes MLL-AF9-mediated leukemogenesis
door: Sumin Koo, et al.
Gepubliceerd in: (2010-10-01)

Dimerization of MLL fusion proteins immortalizes hematopoietic cells.
door: Martin, M, et al.
Gepubliceerd in: (2003)

Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications.
door: Milne, T, et al.
Gepubliceerd in: (2005)

Genome-wide analyses reveal new insights into MLL fusion protein recruitment mechanisms
door: Kerry, J
Gepubliceerd in: (2015)

The MLL family of proteins in normal development and disease
door: Milne, TA
Gepubliceerd in: (2020)

MLL associates specifically with a subset of transcriptionally active target genes.
door: Milne, T, et al.
Gepubliceerd in: (2005)

MLL targets SET domain methyltransferase activity to Hox gene promoters.
door: Milne, T, et al.
Gepubliceerd in: (2002)

Research progress in Menin-MLL interaction and its inhibitors in MLL-rearranged leukemia
door: FANG Xinyue, et al.
Gepubliceerd in: (2024-10-01)

The role of MYB in MLL-AF9 leukaemia
door: Lau, IJ
Gepubliceerd in: (2019)

Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF.
door: Dou, Y, et al.
Gepubliceerd in: (2005)

Trithorax and polycomb cooperation in MLL fusion acute leukemia
door: Helene Méreau, et al.
Gepubliceerd in: (2013-06-01)

RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction.
door: Wilkinson, A, et al.
Gepubliceerd in: (2013)

MLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugs
door: Silvia Maifrede, et al.
Gepubliceerd in: (2017-08-01)

Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors.
door: Milne, T, et al.
Gepubliceerd in: (2005)

Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between AF4-MLL and MLL-AF4 fusions
door: Clara Bueno, et al.
Gepubliceerd in: (2019-06-01)

The role of DOT1L in MLL-AF4 leukaemia
door: Godfrey, L
Gepubliceerd in: (2018)

RUNX1 Is a Key Target in t(4;11) Leukemias that Contributes to Gene Activation through an AF4-MLL Complex Interaction
door: Wilkinson, A, et al.
Gepubliceerd in: (2013)

MLL-TET1 fusion protein promotes immortalization of myeloid progenitor cells and leukemia development
door: Hyeng-Soo Kim, et al.
Gepubliceerd in: (2017-11-01)

IMPDH inhibition activates TLR‐VCAM1 pathway and suppresses the development of MLL‐fusion leukemia
door: Xiaoxiao Liu, et al.
Gepubliceerd in: (2023-01-01)

MLL5 expression as a biomarker for DNA hypermethylation and sensitivity to epigenetic therapy.
door: Milne, T
Gepubliceerd in: (2014)

Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia
door: Diana Schotte, et al.
Gepubliceerd in: (2010-10-01)

SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformation
door: James Ropa, et al.
Gepubliceerd in: (2019-09-01)

Proof equivalence in MLL is PSPACE-complete
door: Willem Heijltjes, et al.
Gepubliceerd in: (2016-03-01)

Interaction of MLL amino terminal sequences with menin is required for transformation.
door: Caslini, C, et al.
Gepubliceerd in: (2007)

TET1 plays an essential oncogenic role in MLL-rearranged leukemia
door: Jaenisch, Rudolf, et al.
Gepubliceerd in: (2014)

Why are so many MLL lysine methyltransferases required for normal mammalian development?
door: Crump, N, et al.
Gepubliceerd in: (2019)

MLL5 expression as a biomarker for DNA hypermethylation and sensitivity to epigenetic therapy
door: Thomas A. Milne
Gepubliceerd in: (2014-09-01)

Pro isomerization in MLL1 PHD3-bromo cassette connects H3K4me readout to CyP33 and HDAC-mediated repression.
door: Wang, Z, et al.
Gepubliceerd in: (2010)

ASXLs binding to the PHD2/3 fingers of MLL4 provides a mechanism for the recruitment of BAP1 to active enhancers
door: Yi Zhang, et al.
Gepubliceerd in: (2024-06-01)

Next generation sequencing techniques reveal molecular mechanisms of MYB regulation and function in MLL-AF9 Leukemia
door: Lau, I, et al.
Gepubliceerd in: (2017)

Development of an orally bioavailable selective inhibitor of the menin-MLL
door: Hai-Jing Zhong, et al.
Gepubliceerd in: (2023-09-01)

Investigating H3K4 methylation by SET1/MLL complexes
door: Au, HYA
Gepubliceerd in: (2023)